NEW YORK--(BUSINESS WIRE)--Actylis and Novo Nordisk Pharmatech A/S have entered into an agreement for the distribution of pharmaceutical grade Benzalkonium Chloride (BKC) to the pharmaceutical and medical device markets in Germany, Spain, Portugal, UK and Ireland. By combining Novo Nordisk Pharmatech’s leading position as a manufacturer of the highest standards of pharmaceutical grade quaternary ammonium compounds (Quats), with Actylis’ expertise and infrastructure in critical raw material distribution, we aim to provide our customers with the best end-to-end service and quality..

纽约--（商业新闻短讯）--Actylis和Novo Nordisk Pharmatech A/S已经签订了一项协议，将药物级苯扎氯铵（BKC）分销到德国、西班牙、葡萄牙、英国和爱尔兰的制药和医疗器械市场。通过将诺和诺德制药技术公司（Novo Nordisk Pharmatech）作为制药级季铵化合物（QUAT）最高标准制造商的领先地位与Actylis在关键原材料分销方面的专业知识和基础设施相结合，我们旨在为客户提供最佳的端到端服务和质量。

Ian Jenning, SVP-President Europe at Actylis explains: ”This new agreement, built on our existing partnership in North America, represents a major opportunity for Actylis Europe to complete our pharmaceutical product portfolio while supporting the development of Novo Nordisk Pharmatech BKC for new applications”..

Actylis欧洲高级副总裁伊恩·詹宁（IanJenning）解释说：“这项新协议建立在我们在北美现有合作伙伴关系的基础上，为Actylis欧洲提供了一个重大机会，可以完成我们的药品组合，同时支持诺和诺德制药技术有限公司（Novo Nordisk Pharmatech BKC）的新应用开发。”

“We are thrilled to strengthen our collaboration with Actylis; this will extend our high standards to these fundamental European markets. We look forward to a successful partnership in the coming years,” says Samia Kappe, Chief Commercial Officer at Novo Nordisk Pharmatech A/S.

诺和诺德制药公司首席商务官萨米娅·卡佩（Samia Kappe）表示：“我们很高兴能加强与Actylis的合作；这将把我们的高标准扩展到这些基本的欧洲市场。我们期待着在未来几年建立成功的合作关系。”

About Actylis

关于Actylis

Actylis is a manufacturer and global distributor of critical raw materials and ingredients for the life science industry. Our global operations include R&D facilities, GMP and non-GMP manufacturing plants, sourcing and warehousing hubs, as well as quality assurance teams and sales offices at strategic locations.

Actylis是生命科学行业关键原材料和配料的制造商和全球分销商。我们的全球业务包括研发设施、GMP和非GMP制造工厂、采购和仓储中心，以及战略位置的质量保证团队和销售办事处。

Through our unique hybrid model of global distribution and manufacturing, Actylis offers a remarkable breadth of custom solutions for the supply of pharmaceutical intermediates, regulatory starting materials, APIs and excipients for small molecule manufacturing projects through clinical trials to commercial launch..

通过我们独特的全球分销和制造混合模式，Actylis通过临床试验到商业启动，为小分子制造项目的药物中间体、监管起始材料、原料药和赋形剂的供应提供了广泛的定制解决方案。

About Novo Nordisk Pharmatech

About Novo Nordisk Pharmatech

Novo Nordisk Pharmatech A/S is a global and leading manufacturer of pharmaceutical ingredients for the pharmaceutical and biopharmaceutical industries. The company specializes in Quats (Benzalkonium Chloride) used as active pharmaceutical ingredients (APIs) and excipients in the highest available quality standard – and Recombinant Insulin for use in cell culture media to enhance cell growth, viability, and productivity..

诺和诺德制药技术公司是一家全球领先的制药和生物制药行业原料药制造商。该公司专门生产以最高质量标准用作活性药物成分（API）和赋形剂的季铵盐（苯扎氯铵），以及用于细胞培养基以增强细胞生长，活力和生产力的重组胰岛素。

The products comply with the latest pharmacopeial standards and are extensively supported by CEPs, DMFs and a comprehensive regulatory and quality assurance document package. In addition, the manufacturing site in Køge (Denmark) is audited by the Danish Medicines Agency and US FDA.

这些产品符合最新的药典标准，并得到CEPs、DMFs和全面的监管和质量保证文件包的广泛支持。此外，科赫（丹麦）的生产基地由丹麦药品管理局和美国FDA进行审计。